OS Therapies Incorporated Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for OS Therapies Incorporated (OSTX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-8.88-7.79-6.25-7.42-6.03
Depreciation & Amortization0.000.000.000.000.00
Stock Based Compensation0.290.000.000.000.00
Change in Working Capital-0.132.020.950.570.96
Change in Accounts Payable-1.051.350.220.860.00
Change in Other Working Capital0.922.760.73-0.280.96
Other Operating Activities0.012.760.360.372.38
Net Cash from Operating Activities-7.28-3.01-3.79-4.40-2.41
Investing Activities
Capital Expenditures0.000.000.00-0.010.00
Other Investing Activities0.000.000.230.210.16
Net Cash from Investing Activities0.000.000.230.200.16
Financing Activities
Debt Repayment-0.250.000.000.00-0.12
Common Stock Issued5.230.000.000.000.00
Dividends Paid-31.250.000.000.000.00
Other Financing Activities37.30-0.28-0.170.100.00
Net Cash from Financing Activities12.782.873.653.053.48
Summary
Net Change in Cash5.49-0.130.09-1.151.22
Cash at Beginning of Period0.040.170.081.230.00
Cash at End of Period5.530.040.170.080.00
Free Cash Flow-7.28-3.01-3.79-4.41-2.42
Supplemental Disclosures
Interest Paid0.000.000.000.010.01